Have your own idea? Try our Stock Screener
Over the last 7 days, the Pharma industry has dropped 1.6%, driven by Hansoh Pharmaceutical Group declining 3.0%. In contrast, Sino Biopharmaceutical has gained 8.8%. As for the longer term, the industry's performance has been flat for the past year. Earnings are forecast to grow by 11% annually.
Has the Hong Kong Pharma Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Fri, 14 Feb 2025 | HK$415.4b | HK$461.6b | HK$31.8b | 8.4x | 13x | 0.9x |
Sun, 12 Jan 2025 | HK$400.2b | HK$459.2b | HK$31.7b | 8.1x | 12.6x | 0.9x |
Tue, 10 Dec 2024 | HK$452.3b | HK$462.5b | HK$31.9b | 8.5x | 14.2x | 1x |
Thu, 07 Nov 2024 | HK$444.5b | HK$467.8b | HK$32.5b | 8.3x | 13.7x | 1x |
Sat, 05 Oct 2024 | HK$532.1b | HK$475.1b | HK$33.0b | 8.3x | 16.1x | 1.1x |
Mon, 02 Sep 2024 | HK$443.8b | HK$474.5b | HK$32.9b | 7.8x | 13.5x | 0.9x |
Wed, 31 Jul 2024 | HK$410.9b | HK$459.0b | HK$32.6b | 7.4x | 12.6x | 0.9x |
Fri, 28 Jun 2024 | HK$441.0b | HK$461.8b | HK$33.8b | 8.3x | 13.1x | 1x |
Sun, 26 May 2024 | HK$459.0b | HK$463.0b | HK$33.7b | 8.5x | 13.6x | 1x |
Tue, 23 Apr 2024 | HK$423.1b | HK$464.6b | HK$33.8b | 7.5x | 12.5x | 0.9x |
Thu, 21 Mar 2024 | HK$463.2b | HK$470.3b | HK$33.3b | 7.7x | 13.9x | 1x |
Sat, 17 Feb 2024 | HK$433.2b | HK$472.8b | HK$33.8b | 7x | 12.8x | 0.9x |
Mon, 15 Jan 2024 | HK$456.0b | HK$472.1b | HK$33.7b | 7.6x | 13.5x | 1x |
Wed, 13 Dec 2023 | HK$478.4b | HK$471.7b | HK$33.7b | 7.5x | 14.2x | 1x |
Fri, 10 Nov 2023 | HK$491.1b | HK$469.3b | HK$31.9b | 7x | 15.4x | 1x |
Sun, 08 Oct 2023 | HK$424.5b | HK$469.6b | HK$31.6b | 6.7x | 13.4x | 0.9x |
Tue, 05 Sep 2023 | HK$434.9b | HK$470.4b | HK$31.7b | 6.9x | 13.7x | 0.9x |
Thu, 03 Aug 2023 | HK$467.5b | HK$446.3b | HK$27.8b | 8.8x | 16.8x | 1x |
Sat, 01 Jul 2023 | HK$494.0b | HK$445.0b | HK$27.7b | 9.7x | 17.8x | 1.1x |
Mon, 29 May 2023 | HK$519.2b | HK$449.7b | HK$28.0b | 8.6x | 18.5x | 1.2x |
Wed, 26 Apr 2023 | HK$552.6b | HK$453.5b | HK$28.8b | 8.9x | 19.2x | 1.2x |
Fri, 24 Mar 2023 | HK$547.9b | HK$446.6b | HK$36.8b | 10x | 14.9x | 1.2x |
Sun, 19 Feb 2023 | HK$607.0b | HK$445.5b | HK$35.3b | 11.7x | 17.2x | 1.4x |
Tue, 17 Jan 2023 | HK$650.0b | HK$448.3b | HK$35.8b | 11x | 18.2x | 1.4x |
Thu, 15 Dec 2022 | HK$625.2b | HK$441.9b | HK$34.7b | 10.5x | 18x | 1.4x |
Sat, 12 Nov 2022 | HK$575.0b | HK$436.1b | HK$33.8b | 9.1x | 17x | 1.3x |
Mon, 10 Oct 2022 | HK$527.2b | HK$516.1b | HK$39.3b | 7.9x | 13.4x | 1x |
Wed, 07 Sep 2022 | HK$545.5b | HK$520.6b | HK$40.9b | 9.7x | 13.3x | 1x |
Fri, 05 Aug 2022 | HK$581.9b | HK$512.6b | HK$51.9b | 7.6x | 11.2x | 1.1x |
Sun, 03 Jul 2022 | HK$637.0b | HK$514.6b | HK$52.2b | 9.5x | 12.2x | 1.2x |
Tue, 31 May 2022 | HK$590.1b | HK$514.5b | HK$51.9b | 8.8x | 11.4x | 1.1x |
Thu, 28 Apr 2022 | HK$557.1b | HK$518.4b | HK$52.0b | 8.6x | 10.7x | 1.1x |
Sat, 26 Mar 2022 | HK$651.1b | HK$505.3b | HK$48.3b | 9x | 13.5x | 1.3x |
Mon, 21 Feb 2022 | HK$696.3b | HK$498.6b | HK$44.0b | 9.9x | 15.8x | 1.4x |
15.8x
Which industries have driven the changes within the Hong Kong Healthcare industry?
HK Market | 2.02% | |
Healthcare | -0.85% | |
Pharma | -1.63% | |
Pharma | -1.63% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
1177 Sino Biopharmaceutical | HK$3.23 | 8.8% +HK$4.7b | 2.5% | PE25.6x | |
1093 CSPC Pharmaceutical Group | HK$4.80 | 5.5% +HK$2.9b | -22.7% | PE10x | |
3320 China Resources Pharmaceutical Group | HK$5.43 | 3.2% +HK$1.1b | 6.3% | PE8.4x | |
512 Grand Pharmaceutical Group | HK$4.59 | 5.3% +HK$805.4m | 29.7% | PE6.7x | |
2096 Simcere Pharmaceutical Group | HK$7.00 | 3.9% +HK$644.3m | 26.8% | PS2.6x |